FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/032938 [Registered on: 19/04/2021] Trial Registered Prospectively
Last Modified On: 16/04/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Tea]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   An attempt in cases of overweight with a simple preparation of tea  
Scientific Title of Study   A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF TAMALA TEA AND GREEN TEA IN OVER WEIGHT 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shaily Agarwal 
Designation  Doctor 
Affiliation  Sri Sri College of Ayurvedic Science and Research Hospital 
Address  DEPARTMENT OF PG STUDIES IN SWASTHAVRITTA, SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH, BANGALORE.

Bangalore Rural
KARNATAKA
560082
India 
Phone  9986527310  
Fax    
Email  shaily04.agarwal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rudresh S 
Designation  Doctor 
Affiliation  Sri Sri College of Ayurvedic Science and Research Hospital 
Address  Associate Professor Department of PG Studies in Swasthavritta Sri Sri College of Ayurvedic Science and Research Bangalore

Bangalore Rural
KARNATAKA
560082
India 
Phone  8123847731  
Fax    
Email  dr.rudresh86@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shaily Agarwal 
Designation  Doctor 
Affiliation  Sri Sri College of Ayurvedic Science and Research Hospital 
Address  Department of PG Studies in Swasthavritta Sri Sri College of Ayurvedic Science and Research Bangalore

Bangalore Rural
KARNATAKA
560082
India 
Phone  9986527310  
Fax    
Email  shaily04.agarwal@gmail.com  
 
Source of Monetary or Material Support  
Samhitas , contemporary modern texts, reputed journals, research articles,web sources and related work from different universities 
 
Primary Sponsor  
Name  Dr Shaily Agarwal 
Address  Department of PG Studies in Swasthavritta Sri Sri College of Ayurvedic Science and Research Bangalore 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shaily Agarwal  Sri Sri College of Ayurvedic Science and Research Hospital  Department of PG Studies in Swasthavritta Sri Sri College of Ayurvedic Science and Research Bangalore
Bangalore
KARNATAKA 
9986527310

shaily04.agarwal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Sri Institutional ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E65-E68||Overweight, obesity and other hyperalimentation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Green Tea  Green Tea available in the market proved to be good for weight loss Dose-60ml,6times/day Route of Administration-Oral Time of study-21 days  
Intervention  Tamala Tea  Tamaladi Tea, consists of basic ingredients available in every kitchen which is cost-effective and easily available like Tamala(cinnamon),Methi seeds,Coriander seeds and jeera seeds which is taken in equal quantity and made into powder form and made into tea by adding 2gms in hot water at once Dose-60ml,6times/day Route of Administration-Oral Time of Study-21 days 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1.Subjects diagnosed over-weight will be included with BMI in between 25 to 29.9kg/m2
2.Subjects of age group between 21 to 45 years will be included irrespective of their gender, religion and socio-economic status  
 
ExclusionCriteria 
Details  1.Obese subjects above BMI 30
2.Over-weight due to systemic diseases
3.Subjects taking drugs like NSAIDS, anti-histamines, oral contraceptives, sulphonamides etc.,
4.Lactating and pregnant women 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
-BMI and Anthropometry measurement will be evaluated(Assessment Criteria)
1.To Evaluate the effect of Tamaladi Tea in Over-weight
2.To re-evaluate the effect of Green Tea in over-weight
3.To Compare the efficacy of Tamaladi Tea and Green Tea in over-weight
 
10thday,21st day 
 
Secondary Outcome  
Outcome  TimePoints 
1.Inch loss  10th day,21st day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/05/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [shaily04.agarwal@gmail.com].

  6. For how long will this data be available start date provided 15-01-2022 and end date provided 15-03-2027?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Over-weight is defined as a BMI between 25 and 29.9 kg/m2 and as abnormal or excessive fat accumulation that may impair health. The World Health Organization (WHO) has declared over-weight as one of the top 10 health risks in the world .In 2016 ,more than 1.9 billion adults ,18 years and older were over-weight .Of these over 650 million were obese.
Over-weight is caused due to poor and improper food habits, chronic imbalance between intake and actual energy needs of the body and physical inactivity.
Over-weight is considered as an intermediate risk factor for major chronic diseases including Obesity, Diabetes ,Heart disease, Stroke, Cancer and Chronic respiratory disease.
 
Close